Tuesday, July 17, 2012

FDA approves Vivus weight-loss drug Qsymia

The Mountain View-based company's (NASDAQ: VVUS) drug, a combination of the generic weight loss drug phentermine and the anti-seizure drug topiramate, can be used by obese or overweight adults who have high-blood pressure, diabetes or high cholesterol.
The company's website late Tuesday afternoon featured a screen promoting Qsymia with a sash that said, "Now approved."

No comments:

Post a Comment